Holen Sie sich die Stockscreener-App
100.06
2.85%
-2.94
Handel nachbörslich:
101.69
1.63
+1.63%
Schlusskurs vom Vortag:
$103.00
Offen:
$102.66
24-Stunden-Volumen:
1.55M
Relative Volume:
1.56
Marktkapitalisierung:
$6.51B
Einnahmen:
$1.54B
Nettoeinkommen (Verlust:
$233.56M
KGV:
29.72
EPS:
3.3669
Netto-Cashflow:
$348.64M
1W Leistung:
+7.72%
1M Leistung:
+18.65%
6M Leistung:
+70.31%
1J Leistung:
+35.47%
1-Tages-Spanne:
$98.00
$102.66
1-Wochen-Bereich:
$92.15
$103.89
52-Wochen-Spanne:
$47.25
$103.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
100.06 | 6.71B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
15.87 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.61 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
80.23 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
578.43 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-12-12 | Hochstufung | Truist | Hold → Buy |
| 2025-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-08-12 | Herabstufung | Truist | Buy → Hold |
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
Lantheus explores $7B sale: report - The Business Journals
Truist Financial Maintains Lantheus(LNTH.US) With Buy Rating - Moomoo
Lantheus Holdings gains after report it's evaluating a sale after offer - MSN
Avoiding Lag: Real-Time Signals in (LNTH) Movement - Stock Traders Daily
Lantheus (LNTH) Considers Sale Following Curium Acquisition Prop - GuruFocus
Lantheus Holdings stock hits 52-week high at 101.01 USD By Investing.com - Investing.com India
Lantheus Holdings (LNTH) Evaluates $7 Billion Sale After Curium Offer - GuruFocus
Lantheus (LNTH) Considers Sale Following $7 Billion Takeover Pro - GuruFocus
Lantheus weighs potential $7 billion sale after Curium’s offer, Bloomberg News reports - WSAU
Lantheus Holdings shares jump on report co is exploring a sale By Investing.com - Investing.com South Africa
Is Lantheus Holdings Inc (LNTH) Overvalued After 9.1% Rally? GF - GuruFocus
Lantheus weighs potential $7 billion sale after Curium's offer, Bloomberg News reports - Reuters
Lantheus Holdings shares jump on report co is exploring a sale - Investing.com India
Lantheus Explores Potential $7 Billion Sale Following Offer From Curium - Bloomberg.com
Lantheus weighs potential $7 billion sale, Bloomberg News reports - marketscreener.com
Lantheus weighs potential $7 billion sale following offer from CuriumBloomberg news - marketscreener.com
Lantheus Holdings stock hits 52-week high at 101.01 USD - Investing.com
Lantheus Weighs Potential $7 Billion Sale Following Offer From Curium - Bloomberg.com
How The Story On Lantheus Holdings (LNTH) Is Shifting With PYLARIFY And Pipeline Expectations - Yahoo Finance
Earnings Preview: Lantheus to Report Financial Results Pre-market on May 07 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting - The Manila Times
New scans for prostate cancer and blood clots head to LA meeting - Stock Titan
A Look at Lantheus Holdings Inc (LNTH) After 3.5% Gain -- GF Val - GuruFocus
Should Lantheus’ Q1 Beat And ASCO 2026 Pipeline Update Require Action From Lantheus Holdings (LNTH) Investors? - simplywall.st
These analysts raise their forecasts on Lantheus after upbeat Q1 results - MSN
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology ... - Caledonian Record
Cancer trial data on LNTH-2403 and prostate imaging headed to ASCO 2026 - Stock Titan
Overheating Stocks: iHeartMedia, Array, Lantheus Under ScrutinyNews and Statistics - IndexBox
Director James H. Thrall receives 4,137 Lantheus (LNTH) shares in grant - Stock Titan
Lantheus (LNTH) director Julie McHugh receives 4,137-share stock grant - Stock Titan
Lantheus (LNTH) director receives 4,137-share stock grant in Form 4 filing - Stock Titan
Lantheus (LNTH) director Maeusli Heinz Christoph receives 4,137-share stock grant - Stock Titan
Director at Lantheus (NASDAQ: LNTH) receives 4,137-share stock grant - Stock Titan
Lantheus (NASDAQ: LNTH) director Gary J. Pruden awarded 4,137 shares - Stock Titan
Lantheus Holdings (LNTH) grants director 4,137 common shares - Stock Titan
Lantheus (LNTH) director granted 4,137 common shares - Stock Titan
Lantheus Holdings (LNTH) director granted 4,137 common shares in Form 4 filing - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy With 10.83% Upside Potential - DirectorsTalk Interviews
Lantheus Holdings (LNTH) price target increased by 10.39% to 103.33 - MSN
Lantheus Holdings Inc stock (US5156731020): analysts see upside after recent volatility - AD HOC NEWS
Lantheus Holdings Inc stock (US5156731020): Q1 2026 earnings beat and renewed interest in radiopharm - AD HOC NEWS
Lantheus Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LNTH) 2026-05-15 - Seeking Alpha
Janus Henderson (LNTH) holds 4.77M shares of Lantheus, 7.4% stake disclosed - Stock Titan
We Think You Should Be Aware Of Some Concerning Factors In Lantheus Holdings' (NASDAQ:LNTH) Earnings - Sahm
Lantheus Holdings stock (US5156731020): Q1 earnings beat sparks 44% YTD rally - AD HOC NEWS
Lantheus reiterates $1.4B-$1.45B 2026 revenue outlook while targeting PYLARIFY TRUVU transition in Q4 - MSN
Discipline and Rules-Based Execution in LNTH Response - Stock Traders Daily
Earnings call transcript: Lantheus Holdings beats Q1 2026 expectations By Investing.com - Investing.com Nigeria
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.02%
5.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):